Omission of Post-Operative Radiation in Patients with Intermediate Pathological Risk Features and Negative Two Week Post-Operative ctHPVDNA (OPERATION Trial)
- Sponsor:
- MUSC
- Sponsor Study ID:
- CTO#104270
- CTO #:
- 104270
- NCT Number:
- NCT07513389
- Phase:
- II
- Protocol Type:
- Treatment
- Age Group:
- Adults
- Disease Sites:
- Lip, Oral Cavity and Pharynx
- Study Objectives:
- To assess the local-regional control at 2 years after definitive surgery and salvage radiotherapy/chemotherapy or surgery.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Chera, Bhishamjit, at cherabs@musc.edu .
- Study Coordinator, Langley, Madelyn, at langlema@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina